Pii Expands US and UK OperationsBy
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) based in Hunt Valley, Maryland, has completed the expansion of its manufacturing facility. This expansion, together with the purchase of new 30 0L fluid beds for solvent coating, is in preparation for future commercial approvals.
Pii has over 40 products pending approval with the US Food and Drug Administration In addition, Pii's UK subsidiary, Pharmaterials, has added 11 new manufacturing suites for the European market. Steve King, Pii's senior vice president, noted: “The increased capacity and capabilities in the USA and UK will support Pii's future growth with further expansions planned in 2015 and beyond.”
Pii provides preformulation testing, formulation development, clinical and commercial GMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms, clinical packaging and labeling, clinical trial kit building and distribution, analytical and QP services. Pii's facilities include manufacturing and containment suites, automated packaging lines and a wide selection of equipment.